| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pathology and Immunology, Monash University Medical School [B. H. T., R. Q., V. B. R.], and Department of Neurosurgery, Alfred Hospital [W. L. E.], Melbourne 3181, Australia
Twenty-one human intracranial tumors comprising 15 astrocytomas and 6 meningiomas and 26 ethylnitrosourea-induced rat neural tumors comprising 7 astrocytomas and 9 schwannomas were examined by indirect immunofluo-rescence for reactivity with a human anti-actin antibody. In cryostat sections both human and rat astrocytomas showed an increased reaction with the anti-actin antibody compared to normal astrocytes, and the reaction with astrocytomas was greater than that with meningiomas. Malignant rat schwannomas also showed prominent anti-actin staining contrasting with the negative reaction in normal Schwann cells. These in vivo observations were paralleled by concurrent studies with impression films and in vitro monolayer cultures of tumor tissue. The results, reviewed in the light of previous studies of anti-actin antibody reactivity with other nonneural tumors, suggest that an enhanced actin expression in vivo may be a general feature of the neoplastic state and that this increased expression may be more pronounced in malignant than in benign tumors.
1 This research was supported by the Anti-Cancer Council and the National Health and Medical Research Council, Australia.
Received 5/20/77. Accepted 9/ 6/77.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |